Clinical Decision Support Systems (CDSS) Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Clinical Decision 
Support Systems (CDSS) 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t he  l a t e s t  r e po r t  b y  I MA R C  G r o up ,  t i t l e d  " C l i n i c a l  D e c i s i o n  S u p p o r t  
S ys t e m s  ( C D S S )  M ar k e t :  G l o b a l  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o wt h ,  O p p o r t u n i t y  
an d  F o r e c a s t  2 02 4 - 2 0 32 , "  g l o b a l  c l i n i ca l  d e c i s i o n  s u p p o r t  s y s t em s  ( C D S S )  ma r k e t  s i z e  
r ea c h e d  U S $  1 . 6  B i l l i on  i n  2 0 2 3 .
Fac tors  A f fect ing  t he  Growth  of  the  C l in ica l  Dec is ion  Suppor t  Sys tems 
Report (CDSS)  Indust ry :
In tegra t ion  w i t h  E lec t ron ic  Hea l t h  Records  ( EHRs) :
Highlight and T he  s e a m l e s s  i n te g r a t i on  o f  c l i n i c a l  d e c i s i on  s u p po r t  s y s t e m s  ( C D S S )  w i t h  e l e c t r o n i c  
he a l t h  r e co r d s  h a s  b ee n  a  p i v o ta l  f a c t o r  i n  t he  g r o w th  o f  t h e  i n du s t r y .  T h i s  i n te g r a t i on  
en a b l e s  h e a l t h ca r e  p r o v i de r s  t o  a c c e s s  a nd  a n a l y z e  p a t i e n t  d a t a  i n  r e a l  t i me ,  
Description f a c i l i t a t i n g  i n f o r me d  c l i n i c a l  d e c i s i o n s  ba s e d  o n  c om p r eh e n s i v e  p a t i en t  h i s t o r i e s ,  
cu r r e n t  m e d i ca t i o n s ,  a n d  o t h e r  r e l e v an t  h e a l t h  i n f o rm a t i o n .  
T he  a b i l i t y  o f  C D S S  to  p r ov i d e  c on t e x t - s p e c i f i c  r e c o mm en d a t i o n s  b y  l e v e r a g i ng  d a t a  
f r o m  E H R s  e n ha n c e s  t h e  qu a l i t y  o f  p a t i e n t  c a r e ,  i n c r ea s e s  o p e r a t i on a l  e f f i c i e n cy ,  a nd  
su p p o r t s  p e r s o na l i z e d  t re a t me n t  p l a ns .  A s  m o r e  h e a l th c a r e  f a c i l i t i e s  a d o p t  a n d  up g r a d e  
t he i r  E H R  s y s t e ms ,  t h e  d e ma n d  f o r  i n t eg r a t ed  C D S S  s o l u t i o ns  co n t i n u e s  to  r i se ,  d r i v i n g  
s i gn i f i c a n t  g r o w th  i n  t he  s e c t o r .
Advancements in Art i f icia l  Intel l igence and Machine Learning:
The rap id  advancements  in  ar t i f i c ia l  in te l l i gence (AI )  and mach ine  learn ing 
(ML)  techno log ies  have  t rans formed the CDSS indust ry .  These techno log ies  
enable  the  deve lopment  o f  more soph is t i ca ted  and  accurate  dec is ion-
suppor t  too ls  tha t  can ana lyze  complex datase ts ,  recogn ize pat te rns ,  and 
Report pred ic t  hea l th  outcomes w i th  g reate r  prec is ion.  
A I  and  ML enhance  the capab i l i t i es  o f  CDSS by  prov id ing  rea l - t ime ins igh ts  
Highlight and and recommendat ions ,  a id ing in  ear ly  d iagnos is ,  and  opt imiz ing t rea tment  
pro toco ls .  The incorporat ion  o f  these cu t t ing-edge technolog ies  in to  CDSS 
improves  c l in ica l  outcomes and  prope ls  the  indust ry  fo rward  by  meet ing  the 
Description growing  demand fo r  da ta-d r iven  and  ev idence-based hea l thcare  so lu t ions .
Increasing Healthcare Data and Demand for Personal ized Medicine:
The exponent ia l  g rowth  o f  hea l thcare  da ta ,  combined  wi th  the r is ing  demand 
for  persona l i zed  medic ine,  s ign i f ican t ly  impacts  the  growth o f  the  CDSS 
indus t ry .  The  ava i lab i l i t y  o f  la rge  vo lumes o f  hea l th  da ta  f rom d iverse  
sources  p rov ides a  r i ch  foundat ion  fo r  CDSS a lgor i thms to  genera te  
accurate  and  persona l ized  c l in ica l  recommendat ions.
Persona l i zed  med ic ine ,  wh ich  ta i lo rs '  t rea tmen t  p lans  to  ind iv idua l  pa t ien t  
charac te r is t i cs ,  re l ies  heav i l y  on  the  soph is t i ca ted  da ta  ana lys is  capab i l i t ies  o f  
CDSS to  in te rp re t  gene t ic  in fo rmat ion ,  pa t ien t  h i s to r ies ,  and  o ther  c r i t i ca l  da ta  
po in ts .  Th is  t rend  toward  cus tomiza t ion  in  hea l thcare  de l i ve ry  underscores  the  
impor tance  o f  CDSS in  fac i l i ta t ing  persona l ized  t rea tmen t  approaches ,  d r iv ing  
Report i ndus t ry  g rowth  as  hea l thcare  p rov ide rs  seek  to  de l ive r  more  pa t ien t -cen te red  ca re .
Highlight and Request  for  a  PDF sample  o f  th is  repor t :  
h t tps : / /www. imarcgroup .com/c l i n ica l -dec is ion -suppor t -sys tems-marke t / reques ts
Description amp le
Report Description
Global  Cl inical  Decision Support  Systems (CDSS) Market  Trends:
The g loba l  c l in ica l  dec is ion  suppor t  sys tems (CDSS)  marke t  i s  w i tness ing  a  s ign i f i can t  su rge ,  d r iven  by  the  
hea l thcare  indus t ry ' s  g rowing  focus  on  reduc ing  d iagnos t ic  e r ro rs  and  enhanc ing  pa t ien t  ca re  ou tcomes.  These  
sys tems leve rage  advanced  ana ly t i cs  and  vas t  da tabases  o f  med ica l  know ledge  to  p rov ide  t ime ly  gu idance  to  
hea l thcare  p ro fess iona ls ,  mak ing  c l in ica l  p rocesses  more  e f f i c ien t  and  ev idence  based .  
The  in teg ra t ion  o f  CDSS w i th  e lec t ron ic  hea l th  reco rds  (EHRs)  has  fu r the r  p rope l led  the i r  adop t ion ,  f ac i l i t a t ing  
persona l ized  pa t ien t  ca re  th rough  rea l - t ime  da ta  ana lys is .  Moreover ,  t he  inc reas ing  p reva lence  o f  ch ron ic  
d iseases  and  the  r i s ing  demand fo r  hea l thcare  se rv ices  have  unde rscored  the  impor tance  o f  CDSS in  
s t reaml in ing  d iagnos t ic  and  t rea tmen t  pa thways ,  con t r ibu t ing  to  the  expans ion  o f  the  marke t .
Look ing  forward,  the  market  is  expec ted to  grow at  a  CAGR of  7 .2% dur ing 2024-2032 .
V iew Report  TOC,  F igures  and Tab les :  
h t tps : / /www. imarcgroup.com/c l in ica l -dec is ion-suppor t -systems-marke t
Component Insights:
• Hardware
• Software
• Services
Product Insights:
• Integrated CDSS
• Standalone CDSS
Report 
Segmentation Type Insights:
• Therapeut ic
• Diagnost ic
Delivery Mode Insights:
• On Premise
• Cloud Based
Model Insights:
• Knowledge Based
• Non-Knowledge Based
Application Insights:
• Drug Al lergy Alerts
• Cl in ical  Guidel ines
Report • Drug-Drug Interactions
• Cl in ical  Reminders
Segmentation • Others
Regional Insights:
• North America
• Europe
• Asia-Pacifi c
• Latin America
• Middle East and Afr ica
• Athenahealth Inc.
• Change Healthcare (United Health Group 
Incorporated)
• Epic Systems Corporation
Competitive • General  E lectr ic  Company
• Internat ional  Business Machines Corporat ion
Landscape 
• Koninkl i jke Phi l ips N.V.
with Key • NextGen Healthcare Inc.
• Oracle Corporation
Players
• Siemens Healthineers AG (Siemens AG)
• Wolters Kluwer N.V.
• Zynx Health Incorporated (Hearst  Business 
Media Corporat ion)
How has the global clinical decision support systems 
(CDSS) market performed so far and how will it perform 
in the coming years?
What are the drivers, restraints, and opportunities in 
the global clinical decision support systems (CDSS) 
market?
Key What are the key regional markets?
Questions 
Answered in Which countries represent the most attractive clinical decision support systems (CDSS) markets?
the Report
What is the breakup of the market based on the 
component?
What is the breakup of the market based on the 
product?
What is the breakup of the market based on the type?
What is the breakup of the market based on the 
delivery mode?
What is the breakup of the market based on the model?
Key What is the breakup of the market based on the application?
Questions What is the competitive structure of the global clinical 
decision support systems (CDSS) market?
Answered in 
Who are the key players/companies in the global clinical 
the Report decision support systems (CDSS) market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  C l i n i c a l  D e c i s i o n  S u p p o r t  S y s t e m s  ( C D S S )  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  C o m p o n e n t
    6 . 1     H a r d w a r e
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     S o f t w a r e
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     S e r v i c e s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
7         M a r k e t  B r e a k u p  b y  P r o d u c t
       
    7 . 1     I n t e g r a t e d  C D S S
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     S t a n d a l o n e  C D S S
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
8     M a r k e t  B r e a k u p  b y  T y p e
    8 . 1     T h e r a p e u t i c
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     D i a g n o s t i c
        8 . 2 . 1  M a r k e t  T r e n d s
Table of         8 . 2 . 2  M a r k e t  F o r e c a s t9     M a r k e t  B r e a k u p  b y  D e l i v e r y  M o d e
    9 . 1     O n  P r e m i s e
        9 . 1 . 1  M a r k e t  T r e n d s
Contents         9 . 1 . 2  M a r k e t  F o r e c a s t
    9 . 2     C l o u d  B a s e d
        9 . 2 . 1  M a r k e t  T r e n d s
        9 . 2 . 2  M a r k e t  F o r e c a s t
1 0     M a r k e t  B r e a k u p  b y  M o d e l
    1 0 . 1     K n o w l e d g e  B a s e d
        1 0 . 1 . 1  M a r k e t  T r e n d s
        1 0 . 1 . 2  M a r k e t  F o r e c a s t
    1 0 . 2     N o n - K n o w l e d g e  B a s e d
        1 0 . 2 . 1  M a r k e t  T r e n d s
        1 0 . 2 . 2  M a r k e t  F o r e c a s t
1 1     M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    1 1 . 1     D r u g  A l l e r g y  A l e r t s
        1 1 . 1 . 1  M a r k e t  T r e n d s
        1 1 . 1 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. i m a rc g ro u p . c o m / c l i n i c a l - d e c i s i o n - s u p p o r t - s y s t e m s - m a
r ke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]